Evidence-based recommendations on delgocitinib (Anzupgo) for treating moderate to severe chronic hand eczema in adults when topical corticosteroids have not worked or are not suitable. There is a ...

*The buy-the-dip impulse still seems to be missing. *Market participants have become more discerning in their review of earnings results. *The Russell 3000 Growth Index is down 2.7% for the week, ...

We're All Ears for Celebrity Buzz! Please enter a name. Please enter a valid email. Please enter a phone number. Please enter a message. Send the Tip! Us Weekly has affiliate partnerships so we may ...